A 65-year-old woman with COPD has FEV1 70% predicted, an mMRC score of 2, a CAT score of 11, and no exacerbations in the past year. She is currently u...

Question

A 65-year-old woman with COPD has FEV1 70% predicted, an mMRC score of 2, a CAT score of 11, and no exacerbations in the past year. She is currently using only short-acting salbutamol as needed. According to the 2023 Canadian Thoracic Society COPD pharmacotherapy guideline, which maintenance regimen is most appropriate?

Accepted Answer

Start dual long-acting bronchodilator therapy with LAMA/LABA

Answer

Continue short-acting salbutamol as needed only

Answer

Start inhaled corticosteroid (ICS) monotherapy

Answer

Start once-daily long-acting muscarinic antagonist (LAMA) monotherapy

Answer

Start chronic low-dose oral prednisone

ca-mccqe1 MCQ (SBA): Chronic obstructive pulmonary disease